300006 logo

Chongqing Lummy Pharmaceutical Co., Ltd. Stock Price

SZSE:300006 Community·CN¥5.7b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

300006 Share Price Performance

CN¥0
-5.09 (-100.00%)
CN¥0
-5.09 (-100.00%)
Price CN¥0

300006 Community Narratives

There are no narratives available yet.

Snowflake Analysis

Flawless balance sheet with weak fundamentals.

0 Risks
0 Rewards

Chongqing Lummy Pharmaceutical Co., Ltd. Key Details

CN¥771.0m

Revenue

CN¥334.4m

Cost of Revenue

CN¥436.6m

Gross Profit

CN¥543.9m

Other Expenses

-CN¥107.3m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
-0.10
56.62%
-13.92%
27.1%
View Full Analysis

About 300006

Founded
1999
Employees
1019
CEO
Rongzhao Qiu
WebsiteView website
www.cqlummy.com

Chongqing Lummy Pharmaceutical Co., Ltd. engages in the research and development, manufacture, and sale of pharmaceutical products in China. The company provides anti-tumor, anti-inflammatory, antibacterial, digestive, anti-virus, blood system, cardiovascular system, acid-base balance nutritional medicine, endocrine system drugs, tumor adjuvant medication, antifungal, and opioid receptor antagonists. Chongqing Lummy Pharmaceutical Co., Ltd. was founded in 1999 and is headquartered in Chongqing, China.

Recent 300006 News & Updates

Recent updates

No updates